Redefining Parkinson's Disease: The Role of Biomarkers and Historical Context

This chapter explores the initiative to redefine the biological classification of Parkinson's disease, focusing on the critical importance of pathological alpha-synuclein biomarkers. It also reviews the history of biomarker research and its impact on diagnosing neurodegenerative diseases, highlighting prospects for better diagnostics and faster clinical trials.